In ₹ Crore except Per Share Latest Annual	LALPATHLAB FY26	METROPOLIS FY26	VIJAYA FY26	THYROCARE FY26	Peer Average
Valuation — at last close
P/E	63.22×	60.27×	87.10×	◆ 50.19×	65.85× -4%
P/B	12.77×	◆ 7.59×	15.74×	14.02×	12.45× +3%
EV/EBITDA	39.29×	◆ 28.22×	43.88×	30.48×	34.19× +15%
Market Cap	₹32,040 Cr	₹11,483 Cr	₹15,066 Cr	₹8,205 Cr	₹11,585 Cr +177%
Growth
Revenue CAGR 3Y	11.06%	12.75%	◆ 21.03%	16.33%	16.70% -34%
Revenue CAGR 5Y	11.81%	10.52%	◆ 16.66%	10.88%	12.69% -7%
Net Income CAGR 3Y	28.35%	10.06%	26.62%	◆ 36.27%	24.32% +17%
Revenue YoY (latest Q)	19.10%	16.62%	22.83%	◆ 25.07%	21.51% -11%
Net Income YoY (latest Q)	27.24%	25.72%	◆ 37.61%	-68.17%	-1.61% +1788%
Profitability
EBITDA Margin	28.32%	24.36%	◆ 41.38%	31.61%	32.45% -13%
Net Income Margin	18.45%	11.62%	◆ 21.24%	19.64%	17.50% +5%
Return on Common Equity	21.57%	13.36%	19.74%	◆ 28.80%	20.63% +5%
Return on Capital Employed	24.78%	15.82%	19.65%	◆ 33.68%	23.05% +8%
Return on Assets	17.39%	9.55%	12.44%	◆ 22.62%	14.87% +17%
Credit & Quality
Total Debt/Equity	◆ 0.00×	0.01×	0.00×	0.00×	0.00× -100%
Interest Coverage	27.22×	10.88×	7.38×	◆ 72.66×	30.31× -10%
Scale — latest FY
Revenue / Total Income	₹2,763 Cr	₹1,646 Cr	₹814 Cr	₹829 Cr	₹1,096 Cr +152%
Net Income	₹510 Cr	₹191 Cr	₹173 Cr	₹163 Cr	₹176 Cr +190%
Total Assets	₹3,146 Cr	₹2,138 Cr	₹1,507 Cr	₹747 Cr	₹1,464 Cr +115%
EPS	₹30.24	₹9.19	₹16.81	₹10.27	₹12.09 +150%
Book Value per Share	₹149.65	₹72.98	₹93.02	₹36.78	₹67.59 +121%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.